? A study done with 57 patients at the Imperial College of London found that doses of capsulated cannabis extract reduced post-operative pain. Doses of five, 10 and 15mg THC were used, and the level of pain relief was shown to be dose-related. A follow-up study is being done with 400 patients, to test a 10mg THC extract.
? A double-blind study done with 24 Multiple Sclerosis patients at the Danish Pain Research Center of the Aarhus University Hospital, found that THC reduced the pain associated with their ailment.
? A study done with 66 MS patients at the Walton Centre for Neurology and Neurosurgery in Liverpool, found that use of a cannabis extract sublingual spray significantly reduced pain and improved sleep patterns.
? A study done with 40 cancer patients at the Lukas Clinic, in Arlesheim, Switzerland, found that capsulated cannabis extracts produced an increase in appetite and pain relief as well as a reduction in nausea.
? A study with rats, published in the September 2003 edition of the journal Pain, showed that the number of the rats’ cannabinoid receptors actually increased after a nerve injury. Researchers concluded that this “may contribute to the therapeutic effects of exogenous cannabinoids on neuropathic pain.”
? All studies cited were presented at the 2003 Symposium on Cannabinoids, International Cannabinoid Research Society (ICRS). www.cannabis-med.org